Insider filing
Traded Nov 4 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
EDSA · NASDAQ · Pharmaceutical Preparations
$1.89−0.05 (−2.58%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Edesa Biotech (EDSA) · oqro.io/stocks/EDSA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Including 24 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Nov 4 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 28 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 5 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 1 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Aug 3 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jul 2 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 16 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 1 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 27 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 1 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 1 · filed 10 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
First insider buy since Mar 2024Traded Feb 26 · filed 14 days later
Since the trade +21.9% · S&P 500 +7.3% · to Nov 16
Edesa Biotech's President paid $3.1K out of pocket for Edesa Biotech shares. 1 other person at Edesa Biotech bought some too, in the same month.
Insider buying
Traded Mar 10 · filed 1 day later
Since the trade −72.6% · S&P 500 +9.3% · to Nov 16
The CEO of Edesa Biotech paid $6.6K out of pocket for Edesa Biotech shares. 1 other person at Edesa Biotech bought some too, in the same month.
Traded Feb 26 – Mar 5, 2026 · largest single transaction ~$67K
Mar 5, 2026~$39K · 10K sh @ $3.90
DetailsOfficial recordTraded Feb 19 – Mar 2, 2026 · largest single transaction 10K
Mar 2, 202610K
DetailsOfficial recordInsider filing
Traded Feb 2 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 5 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Dec 1, 2025 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
9 open-market purchases and 0 open-market sales by insiders of EDSA between Nov 12, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Aug 13, 2026. The data provider lists the next release for Dec 10, 2026; that date may change.
Mar 4, 2026~$43K · 10K sh @ $4.26
DetailsOfficial recordMar 3, 2026~$36K · 10K sh @ $3.63
DetailsOfficial recordMar 2, 2026~$4K · 2,000 sh @ $2.00
DetailsOfficial recordMar 2, 2026~$2.3K · 1,000 sh @ $2.28
DetailsOfficial recordFeb 27, 2026~$67K · 30K sh @ $2.22
DetailsOfficial recordFeb 26, 2026~$32K · 21K sh @ $1.58
DetailsOfficial recordPurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Aug 13, 2026 | None | None | None |
| May 14, 2026 | None | None | None |
| Feb 13, 2026 | None | None | 9 purchases |
| Dec 12, 2025 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies